(0.48%) 5 246.68 points
(0.32%) 39 558 points
(0.75%) 16 511 points
(-0.85%) $78.45
(-1.68%) $2.34
(0.87%) $2 363.50
(1.50%) $28.87
(3.60%) $1 047.20
(-0.24%) $0.924
(-0.04%) $10.80
(-0.24%) $0.794
(-0.29%) $91.33
1.00% INR 2 630.65
Live Chart Being Loaded With Signals
Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, and marketing of generic pharmaceutical formulations in India, the United States, Germany, Brazil, and internationally...
Stats | |
---|---|
Today's Volume | 130 287 |
Average Volume | 262 709 |
Market Cap | 890.33B |
EPS | INR0 ( 2024-02-02 ) |
Next earnings date | ( INR0 ) 2024-05-28 |
Last Dividend | INR8.00 ( 2023-06-23 ) |
Next Dividend | INR0 ( N/A ) |
P/E | 59.52 |
ATR14 | INR2.19 (0.08%) |
Volume Correlation
Torrent Pharmaceuticals Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Torrent Pharmaceuticals Correlation - Currency/Commodity
Torrent Pharmaceuticals Financials
Annual | 2022 |
Revenue: | INR94.64B |
Gross Profit: | INR67.29B (71.10 %) |
EPS: | INR36.79 |
FY | 2022 |
Revenue: | INR94.64B |
Gross Profit: | INR67.29B (71.10 %) |
EPS: | INR36.79 |
FY | 2022 |
Revenue: | INR84.19B |
Gross Profit: | INR58.81B (69.86 %) |
EPS: | INR22.97 |
FY | 2021 |
Revenue: | INR78.86B |
Gross Profit: | INR56.51B (71.66 %) |
EPS: | INR36.99 |
Financial Reports:
No articles found.
Torrent Pharmaceuticals Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
INR0 (N/A) |
INR0 (N/A) |
INR14.00 (N/A) |
INR8.00 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | INR0.500 | 2003-06-10 |
Last Dividend | INR8.00 | 2023-06-23 |
Next Dividend | INR0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 32 | -- |
Total Paid Out | INR130.50 | -- |
Avg. Dividend % Per Year | 0.85% | -- |
Score | 2.7 | -- |
Div. Sustainability Score | 3.99 | |
Div.Growth Potential Score | 6.28 | |
Div. Directional Score | 5.14 | -- |
Year | Amount | Yield |
---|---|---|
2003 | INR0 | 0.00% |
2004 | INR0 | 0.00% |
2005 | INR0 | 0.00% |
2006 | INR0 | 0.00% |
2007 | INR0 | 0.00% |
2008 | INR0 | 0.00% |
2009 | INR0 | 0.00% |
2010 | INR0 | 0.00% |
2011 | INR0 | 0.00% |
2012 | INR0 | 0.00% |
2013 | INR0 | 0.00% |
2014 | INR0 | 0.00% |
2015 | INR0 | 0.00% |
2016 | INR0 | 0.00% |
2017 | INR0 | 0.00% |
2018 | INR7.00 | 1.01% |
2019 | INR8.50 | 0.96% |
2020 | INR7.50 | 0.81% |
2021 | INR17.50 | 1.25% |
2022 | INR20.00 | 1.23% |
2023 | INR22.00 | 1.42% |
2024 | INR0 | 0.00% |
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
PPL.NS | Dividend Junior | 2023-09-18 | Annually | 6 | 0.62% | |
JUBLINGREA.NS | Dividend Junior | 2023-08-10 | Semi-Annually | 4 | 0.47% | |
DPWIRES.NS | Dividend Junior | 2023-09-22 | Annually | 3 | 0.16% | |
ABBOTINDIA.NS | Dividend Knight | 2023-07-20 | Annually | 17 | 0.52% | |
STARPAPER.NS | Dividend Junior | 2023-09-15 | Sporadic | 22 | 1.19% | |
MSUMI.NS | Dividend Junior | 2023-08-09 | Annually | 3 | 0.60% | |
HFCL.NS | Dividend Junior | 2023-09-22 | Sporadic | 7 | 0.19% | |
BIRLACORPN.NS | Ex Dividend Junior | 2023-08-29 | Annually | 21 | 0.41% | |
REFEX.NS | Dividend Junior | 2023-09-14 | Sporadic | 4 | 0.37% | |
KPIGREEN.NS | Dividend Knight | 2023-08-22 | Semi-Annually | 4 | 0.28% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.146 | 1.500 | 7.09 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0 | 1.200 | 0 | 0 | [0 - 0.3] |
returnOnEquityTTM | 0.233 | 1.500 | 8.52 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 0 | 0.800 | -5.00 | -4.00 | [1 - 3] |
quickRatioTTM | 0 | 0.800 | -4.71 | -3.76 | [0.8 - 2.5] |
cashRatioTTM | 0 | 1.500 | -1.111 | -1.667 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | 6.33 | 1.000 | 8.77 | 8.77 | [3 - 30] |
operatingCashFlowPerShareTTM | 47.33 | 2.00 | 10.00 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 47.33 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 0.737 | 1.000 | 1.045 | 1.045 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.234 | 1.000 | 7.32 | 7.32 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 0 | 0.800 | -3.33 | -2.67 | [0.5 - 2] |
Total Score | 3.99 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 58.83 | 1.000 | 4.16 | 0 | [1 - 100] |
returnOnEquityTTM | 0.233 | 2.50 | 9.05 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 47.33 | 2.00 | 10.00 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 1.148 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 47.33 | 2.00 | 10.00 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 3.49 | 1.500 | 10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.155 | 1.000 | 8.62 | 0 | [0.1 - 0.5] |
Total Score | 6.28 |
Torrent Pharmaceuticals
Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, and marketing of generic pharmaceutical formulations in India, the United States, Germany, Brazil, and internationally. It offers products in various therapeutic areas, including cardiovascular, central nervous system, gastrointestinal, women healthcare, diabetology, pain management, gynecology, oncology, and anti-infective, as well as provides vitamins, minerals, and nutrients. The company also provides contract manufacturing services. It has licensing collaborations of Baricitinib, Molnupiravir, and Paxlovid for its Covid portfolio. Torrent Pharmaceuticals Limited was formerly known as Trinity Laboratories and changed its name to Torrent Pharmaceuticals Limited in 1971. The company was founded in 1959 and is based in Ahmedabad, India. Torrent Pharmaceuticals Limited is a subsidiary of Torrent Investments Private Limited.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators